Expliseat is a manufacturer specializing in lightweight aircraft seats, most notably the Titanium Seat, which weighs only 4 kg. This innovative design significantly reduces fuel consumption, yielding potential savings of up to $500,000 per aircraft annually. The seats are crafted from carbon fiber and feature a unique hinge mechanism, ensuring durability while accommodating passengers of all sizes. With ten patents to its name, Expliseat's products also enhance passenger comfort by providing two additional inches of legroom, catering to the evolving needs of airlines and their customers.
Pepette specializes in providing high-quality food products and recipes for cats and dogs. The company offers a range of fresh, organic options including gourmet chicken, beef, and pollock fillets, all developed under the guidance of a veterinary nutritionist. By focusing on the nutritional needs of pets, Pepette ensures that customers receive tailored recipes designed to support the health and well-being of their animals.
Pubstack is an internet company that collects, processes, and visualize events per day. It delivers a product that customers love, they tackle and solve complex technical problems at scale, using the cloud and today’s best open source technologies.
OceanWings is an industrial startup dedicated to reducing carbon emissions in the shipping industry by harnessing wind propulsion technology. The company specializes in designing and manufacturing the Oceanwings system, which integrates wingsails with advanced software to optimize performance. This innovative solution enables oceangoing vessels to achieve significant fuel savings, ranging from 20% to 50%, thereby lowering overall emissions. By providing an automated system that employs wing sail technology, OceanWings aims to enhance the efficiency of maritime transport and contribute to the decarbonization of the shipping sector.
Coave Therapeutics specializes in developing gene therapies aimed at treating rare ocular and central nervous system diseases. The company focuses on innovative solutions for rare retinal disorders, utilizing a recombinant adeno-associated virus that substitutes the viral DNA with a functional copy of the PDE6B gene. This therapeutic approach involves injecting the corrected version of the protein between the photoreceptors and the retinal pigment epithelium, providing patients with effective treatment options for various eye conditions.
Babbar is a provider of SEO services through its software-as-a-service platforms, focusing on enhancing link-building strategies based on extensive knowledge of link and page semantics. The company offers a data analytics platform that simulates search engine algorithms, allowing users to predict and analyze the positioning performance of their web pages. By utilizing advanced techniques such as backlink analysis and fine metrics, Babbar helps SEO professionals, online marketers, and webmasters improve their website performance and visibility in search engine results. Through its proprietary Babbar authority score, the company enables advertisers to gain deeper insights into their web page effectiveness, fostering a more comprehensive understanding of their digital presence.
DessIA is a developer of augmented engineering software that leverages artificial intelligence to streamline product development. The company's platform assists engineers and architects by automating tasks in the early stages of design, generating numerous architectural options, and identifying optimal configurations that align with sustainability and profitability goals. By addressing complex engineering challenges, DessIA enables automotive and mechanical engineers to enhance their efficiency and explore innovative solutions, ultimately reducing lead times and increasing profit margins.
VitaDX is a startup focused on enhancing cancer diagnosis through the application of artificial intelligence and fluorescence imaging technology. Its primary product, VisioCyt®, is designed for the early detection of bladder cancer, utilizing a simple urine sample to improve upon the traditional urinary cytology methods. By integrating machine learning with advanced imaging techniques, VitaDX aims to identify potential abnormalities in the urinary excretory tract. This innovative approach enables healthcare providers to offer more accurate and timely cancer diagnostic services, ultimately leading to improved treatment options and better patient outcomes.
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.
Blacknut is a cloud gaming service that focuses on providing a subscription-based platform for a wide audience, offering over 400 premium games suitable for the entire family. Founded in 2016 by Olivier Avaro, the company is headquartered in Rennes, France, with additional offices in Paris, Seoul, and San Francisco. Blacknut's service is available across Europe, Asia, and North America, compatible with various devices such as mobile phones, set-top boxes, and Smart TVs. The platform utilizes an algorithm to recommend games based on user preferences, allowing players to easily access and discover new titles while engaging with a community of gamers. Blacknut distributes its service directly to consumers and through partnerships with ISPs, device manufacturers, and media companies.
BodyCap, an innovative company based in Hérouville Saint Clair, specializes in the development of miniaturized, wireless electronic sensors for continuous monitoring of patients' physiological variables. Its products enable healthcare professionals to gather real-time data for diagnostic and surveillance purposes, enhancing patient comfort and optimizing the information available to medical staff. BodyCap's technology is applicable in both medical and outpatient settings, making it a valuable tool for monitoring physiological conditions in various contexts, including sports and ergonomics. By focusing on continuous monitoring, BodyCap aims to improve patient care and streamline clinical investigations.
Seaver is a technology startup founded in 2016 and headquartered in Ile-de-France, France. The company focuses on digitalizing the equestrian sports sector by developing innovative riding equipment that leverages the internet of things and performance monitoring. Its products enable riders and horse owners to access live streaming data on their horses' cardio, movement, and workout quality. By providing detailed insights into training and performance, Seaver supports riders in monitoring their horses' progress and health effectively.
Coave Therapeutics specializes in developing gene therapies aimed at treating rare ocular and central nervous system diseases. The company focuses on innovative solutions for rare retinal disorders, utilizing a recombinant adeno-associated virus that substitutes the viral DNA with a functional copy of the PDE6B gene. This therapeutic approach involves injecting the corrected version of the protein between the photoreceptors and the retinal pigment epithelium, providing patients with effective treatment options for various eye conditions.
VitaDX is a startup focused on enhancing cancer diagnosis through the application of artificial intelligence and fluorescence imaging technology. Its primary product, VisioCyt®, is designed for the early detection of bladder cancer, utilizing a simple urine sample to improve upon the traditional urinary cytology methods. By integrating machine learning with advanced imaging techniques, VitaDX aims to identify potential abnormalities in the urinary excretory tract. This innovative approach enables healthcare providers to offer more accurate and timely cancer diagnostic services, ultimately leading to improved treatment options and better patient outcomes.
Qowisio is a global leader that dedicates to low cost and low power cellular network for the IoT (LPWAN). It offers a wide range of connected devices and technological bricks in order to address new use cases for SMBs and blue-chip customers. The company’s products are used in fuel tank monitoring and power metering applications. Qowisio is a France-based company that was founded in 2009.
BodyCap, an innovative company based in Hérouville Saint Clair, specializes in the development of miniaturized, wireless electronic sensors for continuous monitoring of patients' physiological variables. Its products enable healthcare professionals to gather real-time data for diagnostic and surveillance purposes, enhancing patient comfort and optimizing the information available to medical staff. BodyCap's technology is applicable in both medical and outpatient settings, making it a valuable tool for monitoring physiological conditions in various contexts, including sports and ergonomics. By focusing on continuous monitoring, BodyCap aims to improve patient care and streamline clinical investigations.
BodyCap, an innovative company based in Hérouville Saint Clair, specializes in the development of miniaturized, wireless electronic sensors for continuous monitoring of patients' physiological variables. Its products enable healthcare professionals to gather real-time data for diagnostic and surveillance purposes, enhancing patient comfort and optimizing the information available to medical staff. BodyCap's technology is applicable in both medical and outpatient settings, making it a valuable tool for monitoring physiological conditions in various contexts, including sports and ergonomics. By focusing on continuous monitoring, BodyCap aims to improve patient care and streamline clinical investigations.
Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence in the media and on social networks. The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies. Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.
Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence in the media and on social networks. The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies. Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.